EP1025858A1 — Medicinal compositions with relieved bitterness, etc.
Assigned to Eisai R&D Management Co Ltd · Expires 2000-08-09 · 26y expired
What this patent protects
Compositions wherein bitterness, etc. of a drug have been relieved. Namely, compositions containing a basic drug having an unpleasant taste and polyvinyl pyrrolidone and/or copolyvidone; and a method for relieving an unpleasant taste of a drug by adding polyvinyl pyrrolidone and/…
USPTO Abstract
Compositions wherein bitterness, etc. of a drug have been relieved. Namely, compositions containing a basic drug having an unpleasant taste and polyvinyl pyrrolidone and/or copolyvidone; and a method for relieving an unpleasant taste of a drug by adding polyvinyl pyrrolidone and/or copolyvidone. Compositions comprising (1) a basic drug, (2) polyvinyl pyrrolidone and/or copolyvidone and (3) propylene glycol and/or D-sorbitol; compositions comprising (1) a basic drug, (2) polyvinyl pyrrolidone and/or copolyvidone and (4) an antioxidant; and compositions comprising (1) a basic drug, (2) polyvinyl pyrrolidone and/or copolyvidone and (5) a coloring matter or a perfume having sulfate or sulfite.
Drugs covered by this patent
- Ferriprox (DEFERIPRONE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.